Advances of Melatonin-Based Therapies in the Treatment of Disturbed Sleep and Mood

Research output: Chapter in Book/Report/Conference proceedingChapter (Book)Other

2 Citations (Scopus)

Abstract

Melatonin and melatonin agonists offer novel treatments for sleep and mood disorders, particularly where circadian misalignment is also present. The therapies offer both phase-shifting and sleep-promoting effects and have shown potential to treat advanced and delayed sleep-wake phase disorder, non-24-h sleep-wake cycle, jetlag, shift work disorder, insomnia, seasonal affective disorder and major depressive disorder.

Original languageEnglish
Title of host publicationHandbook of Experimental Pharmacology
EditorsHans-Peter Landolt, Derk-Jan Dijk
Place of PublicationCham, Switzerland
PublisherSpringer
Pages305-319
Number of pages15
ISBN (Electronic)9783030112721
ISBN (Print)9783030112707
DOIs
Publication statusPublished - 2019

Publication series

NameHandbook of Experimental Pharmacology
Volume253
ISSN (Print)0171-2004
ISSN (Electronic)1865-0325

Keywords

  • Agomelatine
  • Circadian rhythm
  • Circadin
  • Major depressive disorder
  • Melatonin
  • Melatonin agonist
  • Mood
  • Ramelteon
  • Sleep
  • Tasimelteon

Cite this

Alston, M., Cain, S. W., & Rajaratnam, S. M. W. (2019). Advances of Melatonin-Based Therapies in the Treatment of Disturbed Sleep and Mood. In H-P. Landolt, & D-J. Dijk (Eds.), Handbook of Experimental Pharmacology (pp. 305-319). (Handbook of Experimental Pharmacology; Vol. 253). Springer. https://doi.org/10.1007/164_2018_139